Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate A Markey

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Blood|July 2, 2011
Type I-IFNs control GVHD and GVL responses after transplantationRenee J Robb, Ellen Kreijveld, Rachel D Kuns, et al.
Blood|April 28, 2012
Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantationRenee J Robb, Katie E Lineburg, Rachel D Kuns, et al.
Blood|February 23, 2013
Promoting regulation via the inhibition of DNAM-1 after transplantationMotoko Koyama, Rachel D Kuns, Stuart D Olver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2018
Flt-3L Expansion of Recipient CD8α<sup>+</sup> Dendritic Cells Deletes Alloreactive Donor T Cells and Represents an Alternative to Posttransplant Cyclophosphamide for the Prevention of GVHDKate A Markey, Rachel D Kuns, Daniel J Browne, et al.
Blood|April 17, 2009
Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administrationRachel D Kuns, Edward S Morris, Kelli P A Macdonald, et al.
Nature Medicine|December 1, 2011
Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host diseaseMotoko Koyama, Rachel D Kuns, Stuart D Olver, et al.
Blood|October 1, 2009
Soluble lymphotoxin is an important effector molecule in GVHD and GVLKate A Markey, Angela C Burman, Tatjana Banovic, et al.
The Journal of Clinical Investigation|October 10, 2018
Bone marrow transplantation generates T cell-dependent control of myeloma in miceSlavica Vuckovic, Simone A Minnie, David Smith, et al.
The Journal of Clinical Investigation|August 27, 2014
CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host diseaseKylie A Alexander, Ryan Flynn, Katie E Lineburg, et al.
Blood|December 29, 2025
Enterococcus induces MHC-II expression by the intestinal epithelium during murine graft-versus-host diseaseChi Nguyen, Jennifer Funes, Romina Ghale, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Blood|July 2, 2011
Type I-IFNs control GVHD and GVL responses after transplantationRenee J Robb, Ellen Kreijveld, Rachel D Kuns, et al.
Blood|April 28, 2012
Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantationRenee J Robb, Katie E Lineburg, Rachel D Kuns, et al.
Blood|February 23, 2013
Promoting regulation via the inhibition of DNAM-1 after transplantationMotoko Koyama, Rachel D Kuns, Stuart D Olver, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2018
Flt-3L Expansion of Recipient CD8α<sup>+</sup> Dendritic Cells Deletes Alloreactive Donor T Cells and Represents an Alternative to Posttransplant Cyclophosphamide for the Prevention of GVHDKate A Markey, Rachel D Kuns, Daniel J Browne, et al.
Blood|April 17, 2009
Invariant natural killer T cell-natural killer cell interactions dictate transplantation outcome after alpha-galactosylceramide administrationRachel D Kuns, Edward S Morris, Kelli P A Macdonald, et al.
Nature Medicine|December 1, 2011
Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host diseaseMotoko Koyama, Rachel D Kuns, Stuart D Olver, et al.
Blood|October 1, 2009
Soluble lymphotoxin is an important effector molecule in GVHD and GVLKate A Markey, Angela C Burman, Tatjana Banovic, et al.
The Journal of Clinical Investigation|October 10, 2018
Bone marrow transplantation generates T cell-dependent control of myeloma in miceSlavica Vuckovic, Simone A Minnie, David Smith, et al.
The Journal of Clinical Investigation|August 27, 2014
CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host diseaseKylie A Alexander, Ryan Flynn, Katie E Lineburg, et al.
Blood|December 29, 2025
Enterococcus induces MHC-II expression by the intestinal epithelium during murine graft-versus-host diseaseChi Nguyen, Jennifer Funes, Romina Ghale, et al.
Pageof 8